FOI release

Freedom of Information request on the side effects reported for Benzydamine Hydrochloride (Difflam) (FOI 21/1240)

Published 31 May 2022

FOI 21/1240

13th December 2021

Dear,

Thank you for your FOI request dated 21st November 2021, where you requested information regarding the side effects reported for Benzydamine Hydrochloride (Difflam).

The MHRA collects data concerning any adverse reactions observed to medicines and medical devices through our Yellow Card scheme. Yellow Card data for drugs is routinely published on the Yellow Card website https://yellowcard.mhra.gov.uk/iDAP/ and the information you have requested can be found at the link below:

https://info.mhra.gov.uk/drug-analysis-profiles/dap.html?drug=./UK_EXTERNAL/NONCOMBINED/UK_NON_000454048390.zip&agency=MHRA

If you are dissatisfied with the handling of your request, you have the right to ask for an internal review. Internal review requests should be submitted within two months of the date of this response; and can be addressed to this email address.

Yours sincerely,

FOI Team,

Vigilance and Risk Management of Medicines Division